top of page

Towards a sustainable European vaccine infrastructure
TIMELINE
01 June 2020 to 28 Feb 2023
FUNDING
1.88 M Euro
TRANSVAC-DS aims to consolidate the conceptual and technical design and ultimate implementation of a European vaccine R&D infrastructure.
TRANSVAC-DS Work package structure and flow:
Work packages
WP
Input
Recent News:

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.
Apply for Vaccine R&D services and Training:



This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.
© 2023 European Vaccine Initiative. Designed by European Vaccine Initiative
bottom of page